期刊文献+

奥美拉唑三联疗法治疗幽门螺杆菌所致消化性溃疡的临床观察 被引量:6

Clinical Observation on Peptic Ulcer Caused by Hp Treated with Combination of Omeprazole Trigminy
暂未订购
导出
摘要 目的探讨奥美拉唑三联疗法治疗幽门螺杆菌(Hp)所致消化性溃疡的疗效。方法将86例消化性溃疡患者,随机分为治疗组和对照组。治疗组采用奥美拉唑+克拉霉素+阿莫西林三联疗法;对照组采用奥美拉唑治疗,4周为1个疗程。结果治疗组治疗消化性溃疡总有效率为90.70%,治愈率为64.39%,6个月后复发率为11.11%;对照组总有效率为76.74%,治愈率为37.21%,6个月后复发率为43.75%。两组有效率和复发率比较差异有显著性(P<0.05)。结论奥美拉唑三联疗法对治疗幽门螺杆菌(Hp)所致消化性溃疡有较高的治愈率和较低的复发率。 Objective To discuss the curative effect of combination of omeprazol trigmini on treatment of peptic ulcer caused by Hp.Methods 86 cases of peptic ulcer patient were divided into therapy group and control group.The therapy group was treated with omeprazol trigminy and control group was treated with only omeprazol for 4 weeks as a course.Results The total effective rate was 90.70% in therapy group and 76.74% in control group,curative rate was 64.39% in therapy group and 37.21% in control group,recurrence rate was 11.11% in therapy group and 43.75% in control group after 6 months.There were significant difference between two groups in curative and recurrence rates(P0.05).Conclusion This trigminy method might improve the healing and decrease the recurrence rate for peptic ulcer.
作者 万秀飞
出处 《黑龙江医学》 2011年第10期756-758,共3页 Heilongjiang Medical Journal
  • 相关文献

参考文献3

共引文献50

同被引文献40

  • 1杨燕,刘淳,刘普文.复方丹参滴丸联合奥美拉唑治疗老年胃溃疡疗效观察[J].广东药学院学报,2007,23(5):577-579. 被引量:9
  • 2SotiriosD. Georgopoulos, 1 Vasilios Papastergiou,StylianosKaratapanis. Helicobacter pylori Eradication Therapies in the Eraof Increasing Antibiotic Resistance : A ParadigmShift to ImprovedEfficacy [J]. Gastroenterology Research and Practice, Volume2012, Article ID 757926, 9 pages.
  • 3Schistosomes,liver flukes and Helicobacter pylori. IARCWorking Group on the Evaluation of Carcinogenic Risks to Hu-mans [J]. Lyon,7 -14 June 1994. IARC Monogr Eval CarcinogRisks Hum 1994,61: 1-241.
  • 4WueppenhorstN, Stueger HP, Kist M, Glocker E. Identificationand molecular characterization of triple - and quadruple -resistantHelicobacter pylori clinical isolates in Germany [J]. J AntimicrobChemother,2010 Apr,63(4) :648-653.
  • 5MiendjeDeyi VY,Bontems P,Yanderpas J, Multicenter surveyof routine determinations of resistance of Helicobacter pylori to an-timicrobials over the last 20 years (1990 to 2009) in Belgium[J].JClin Microbiol,2011 Jun,49(6):2200-2209.
  • 6SotiriosD. Georgopoulos, Vasilios Papastergiou, StylianosKaratapanis, Helicobacter pylori Eradication Therapies in the Eraof Increasing Antibiotic Resistance : A Paradigm Shift to ImprovedEfficacy [J].Gastroenterology Research and Practice, 2012 : 976 -982.
  • 7Molina-InfanteJ, Perez-Gllardo B, Fernandez-Bermejo M.Clinical trial : clarithromycin vs. levofloxacin in first -line tripleand sequential regimens for Helicobacter pylori eradication [J].Ali-mentaiy Pharmacology & Therapeutics,2010: 1077-1084.
  • 8Bertleff MJ, Lange JE. Laparoscopic correction of perforted peptic ulcer: first choice A review of literature [ J ] .Surg En- dosc,2010,24(6) : 1231- 1239.
  • 9Kuwabara K, Matsuda S, Fushimi K, Ishikawa KB, Horiguchi H.Community-based evaluation of laparoscopic versus open simple closure of perforated peptic ulcers [ J ]. World Surg, 2011,35 (11) :2485- 2492.
  • 10陈元鸿,伍灵达,王婉梅,等.复方丹参滴丸与雷尼替丁治疗老年胃溃疡的观察[C]//复方丹参滴丸美国FDA2010:548-549.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部